Please assess the completion status of the following clinical trial:

Trial Title: Natural Orifice Translumenal Endoscopic Surgery: Laparoscopic-Assisted Transvaginal Cholecystectomy

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Females who are postmenopausal or who no longer wish to bear children~* Females \>25 years old and \<65 years old~* Diagnosis of biliary disease requiring cholecystectomy~* American Society of Anesthesiology (ASA) Class I or II~* Females who are able to understand and willing to sign an informed consent document~Exclusion Criteria:~* Pregnancy~* BMI \>= 30~* Patients who are still interested in childbearing~* Patients taking immunosuppressive medications or who are immunocompromised~* Patients with acute cholecystitis or history of acute cholecystitis ( as defined by right upper quadrant pain with history of fevers and/or elevated white blood cell count and/or positive ultrasound findings, ie, gallbladder wall thickening or pericholecystic fluid)~* Patients with suspicion of gallbladder cancer~* Patients with history of previous open abdominal surgery~* Patients with untreated common bile duct stones

- Gender: FEMALE
- Minimum Age: 26 Years
- Maximum Age: 64 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).